In animal models with blocked TGF-β signaling, inhibition of ALK5 attenuates bleomycin-induced pulmonary fibrosis [114], and LAP prevents sclerodermatous graft-versus-host disease [115]. Here, TGFB1 is linked to pulmonary fibrosis.